Lexmet 2 Tablet contains Glimepiride 2mg, an oral hypoglycemic agent belonging to the sulfonylurea class, indicated for the management of type 2 diabetes mellitus. It functions primarily by stimulating pancreatic beta cells to release insulin, thereby improving glycemic control in patients with inadequate response to diet and exercise alone. Lexmet 2 is typically prescribed as part of a comprehensive diabetes management plan, which includes dietary modification and regular physical activity. The medication is effective in lowering both fasting and postprandial blood glucose levels, contributing to the reduction of long-term complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy. Glimepiride has a relatively low risk of hypoglycemia compared to other sulfonylureas but caution is advised in patients with hepatic or renal impairment. Common side effects may include hypoglycemia, dizziness, and gastrointestinal disturbances. Dose adjustment may be necessary based on glycemic response and tolerability. Lexmet 2 should be used under medical supervision with regular monitoring of blood glucose and HbA1c levels to optimize therapeutic outcomes. It is contraindicated in type 1 diabetes, diabetic ketoacidosis, and during pregnancy or lactation. Patient education on adherence, recognition of hypoglycemia symptoms, and lifestyle modifications is essential for effective diabetes management.